Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

HIV/AIDS

Engineered protein primes antibody response to HIV

An experimental HIV-1 vaccine has demonstrated immunogenicity in mice, according to recent studies. In the image, a scientist observes test subjects (white mice) in a laboratory

Source: Ragne Kabanova

Researchers administered eOD-GT8 60mer to mice, inducing the production of broadly neutralising antibody precursors

An experimental HIV-1 vaccine has demonstrated immunogenicity in mice, according to studies published concurrently in Cell[1] and Science[2] (online, 18 June 2015), with the results described as “pretty spectacular” by one of the researchers.

The new vaccine is an engineered protein, or immunogen, that binds to a precursor of broadly neutralising antibodies (bnAbs). Achieving such binding has been a major hurdle in the development of an HIV vaccine and the new protein, called eOD-GT8 60mer, represents an important advance towards an effective vaccine.

When administered to mice, eOD-GT8 60mer induced the production of antibodies with characteristics of a certain class of bnAb precursors. “The vaccine appears to work well in our model to ‘prime’ the antibody response,” says David Nemazee, one of the senior study authors.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20068849

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

RPS publications

Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.

Visit rpharms.com

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.